BRPI0418167A - composições farmacêuticas - Google Patents

composições farmacêuticas

Info

Publication number
BRPI0418167A
BRPI0418167A BRPI0418167-0A BRPI0418167A BRPI0418167A BR PI0418167 A BRPI0418167 A BR PI0418167A BR PI0418167 A BRPI0418167 A BR PI0418167A BR PI0418167 A BRPI0418167 A BR PI0418167A
Authority
BR
Brazil
Prior art keywords
pharmaceutical compositions
ethylene carbonate
degradable
governed
chloroform
Prior art date
Application number
BRPI0418167-0A
Other languages
English (en)
Inventor
Michael Ausborn
Thomas Kissel
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0330031A external-priority patent/GB0330031D0/en
Priority claimed from GB0410261A external-priority patent/GB0410261D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BRPI0418167A publication Critical patent/BRPI0418167A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/08—Materials for coatings
    • A61L29/085—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
    • A61L29/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/10—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow
    • A61L2300/604—Biodegradation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Laminated Bodies (AREA)
  • Paints Or Removers (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Biological Depolymerization Polymers (AREA)

Abstract

COMPOSIçõES FARMACêUTICAS. A presente invenção refere-se a um dispositovo implantável dentro de um corpo humano ou animal que compreende unidades de carbonato de etileno da fórmula A-(-C(O)-O-CH~ 2~-CH~ 2~-O-) que possui um teor de carbonato de etileno de 70 a 100% em mol, uma viscosidade intrínseca de 0,4 a 4,0 dI/g medida em clorofórmio a 20 C em uma concentração de 1 g/dI e erosão de superfície que é governada por um mecanismo não-hidrolíco.
BRPI0418167-0A 2003-12-24 2004-12-23 composições farmacêuticas BRPI0418167A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0330031A GB0330031D0 (en) 2003-12-24 2003-12-24 Organic compounds
GB0410261A GB0410261D0 (en) 2004-05-07 2004-05-07 Organic compounds
PCT/EP2004/014682 WO2005063319A1 (en) 2003-12-24 2004-12-23 Parmaceutical compositions

Publications (1)

Publication Number Publication Date
BRPI0418167A true BRPI0418167A (pt) 2007-06-19

Family

ID=34913647

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0418167-0A BRPI0418167A (pt) 2003-12-24 2004-12-23 composições farmacêuticas

Country Status (13)

Country Link
US (2) US20070154520A1 (pt)
EP (1) EP1699503B8 (pt)
JP (1) JP4796506B2 (pt)
KR (1) KR20070015113A (pt)
AT (1) ATE549044T1 (pt)
AU (1) AU2004308654B2 (pt)
BR (1) BRPI0418167A (pt)
CA (1) CA2549601A1 (pt)
ES (1) ES2383374T3 (pt)
PL (1) PL1699503T3 (pt)
PT (1) PT1699503E (pt)
RU (1) RU2363497C2 (pt)
WO (1) WO2005063319A1 (pt)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8741378B1 (en) 2001-06-27 2014-06-03 Advanced Cardiovascular Systems, Inc. Methods of coating an implantable device
WO2007011708A2 (en) 2005-07-15 2007-01-25 Micell Technologies, Inc. Stent with polymer coating containing amorphous rapamycin
WO2007011707A2 (en) 2005-07-15 2007-01-25 Micell Technologies, Inc. Polymer coatings containing drug powder of controlled morphology
US8021678B2 (en) 2006-02-10 2011-09-20 Advanced Cardiovascular Systems, Inc. Implantable medical device with polymer coating in a surface area to volume ratio providing surface erosion characteristics
ES2540059T3 (es) 2006-04-26 2015-07-08 Micell Technologies, Inc. Recubrimientos que contienen múltiples fármacos
CA2667228C (en) 2006-10-23 2015-07-14 Micell Technologies, Inc. Holder for electrically charging a substrate during coating
US11426494B2 (en) 2007-01-08 2022-08-30 MT Acquisition Holdings LLC Stents having biodegradable layers
CA2679712C (en) 2007-01-08 2016-11-15 Micell Technologies, Inc. Stents having biodegradable layers
ES2530862T3 (es) * 2007-02-07 2015-03-06 Cook Medical Technologies Llc Revestimientos de dispositivos médicos para liberar un agente terapéutico a diferentes velocidades
BRPI0810370A2 (pt) * 2007-04-17 2014-10-29 Micell Technologies Inc Stent revestido, e, método para preparar um stent
AU2008256684B2 (en) 2007-05-25 2012-06-14 Micell Technologies, Inc. Polymer films for medical device coating
CN102083397B (zh) 2008-04-17 2013-12-25 米歇尔技术公司 具有生物可吸收层的支架
JP2011528275A (ja) 2008-07-17 2011-11-17 ミセル テクノロジーズ，インク． 薬物送達医療デバイス
US20100086579A1 (en) * 2008-10-03 2010-04-08 Elixir Medical Corporation Macrocyclic lactone compounds and methods for their use
WO2010120552A2 (en) 2009-04-01 2010-10-21 Micell Technologies, Inc. Coated stents
EP3366326A1 (en) 2009-04-17 2018-08-29 Micell Technologies, Inc. Stents having controlled elution
EP2453834A4 (en) 2009-07-16 2014-04-16 Micell Technologies Inc MEDICAL DEVICE DISPENSING MEDICINE
EP2531140B1 (en) 2010-02-02 2017-11-01 Micell Technologies, Inc. Stent and stent delivery system with improved deliverability
US8795762B2 (en) 2010-03-26 2014-08-05 Battelle Memorial Institute System and method for enhanced electrostatic deposition and surface coatings
US8685433B2 (en) 2010-03-31 2014-04-01 Abbott Cardiovascular Systems Inc. Absorbable coating for implantable device
EP2560576B1 (en) 2010-04-22 2018-07-18 Micell Technologies, Inc. Stents and other devices having extracellular matrix coating
ES2566934T3 (es) * 2010-05-10 2016-04-18 INSERM (Institut National de la Santé et de la Recherche Médicale) Métodos y composiciones para el tratamiento de la acumulación de líquido en y/o bajo la retina
WO2012009684A2 (en) 2010-07-16 2012-01-19 Micell Technologies, Inc. Drug delivery medical device
US9636309B2 (en) 2010-09-09 2017-05-02 Micell Technologies, Inc. Macrolide dosage forms
WO2012166819A1 (en) 2011-05-31 2012-12-06 Micell Technologies, Inc. System and process for formation of a time-released, drug-eluting transferable coating
CA2841360A1 (en) 2011-07-15 2013-01-24 Micell Technologies, Inc. Drug delivery medical device
US10188772B2 (en) 2011-10-18 2019-01-29 Micell Technologies, Inc. Drug delivery medical device
KR20150143476A (ko) 2013-03-12 2015-12-23 미셀 테크놀로지즈, 인코포레이티드 생흡수성 생체의학적 임플란트
HK1222313A1 (zh) 2013-05-15 2017-06-30 Micell Technologies, Inc. 可生物吸收的生物医学植入物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5145945A (en) * 1987-12-17 1992-09-08 Allied-Signal Inc. Homopolymers and copolymers having recurring carbonate units
US5263991A (en) * 1992-10-21 1993-11-23 Biomet, Inc. Method for heating biocompatible implants in a thermal packaging line
CA2472404A1 (en) * 1993-07-19 1995-02-02 Angiotech Pharmaceuticals, Inc. Combination of stent and anti-angiogenic factor
IL110787A0 (en) * 1993-08-27 1994-11-11 Sandoz Ag Biodegradable polymer, its preparation and pharmaceutical composition containing it
JP3476604B2 (ja) * 1995-08-22 2003-12-10 鐘淵化学工業株式会社 薬剤を付着・コーティングしたステントの製造方法
US5703200A (en) * 1996-03-15 1997-12-30 Ethicon, Inc. Absorbable copolymers and blends of 6,6-dialkyl-1,4-dioxepan-2-one and its cyclic dimer
US20010007083A1 (en) * 1999-12-29 2001-07-05 Roorda Wouter E. Device and active component for inhibiting formation of thrombus-inflammatory cell matrix
EP1439868A2 (en) * 2001-10-31 2004-07-28 Edwards Lifesciences Corporation Drug eluting radially expandable tubular stented grafts

Also Published As

Publication number Publication date
US20110305742A1 (en) 2011-12-15
EP1699503A1 (en) 2006-09-13
PT1699503E (pt) 2012-06-06
EP1699503B1 (en) 2012-03-14
RU2363497C2 (ru) 2009-08-10
US20070154520A1 (en) 2007-07-05
RU2006126779A (ru) 2008-01-27
KR20070015113A (ko) 2007-02-01
ES2383374T3 (es) 2012-06-20
WO2005063319A8 (en) 2005-09-09
AU2004308654A1 (en) 2005-07-14
CA2549601A1 (en) 2005-07-14
WO2005063319A1 (en) 2005-07-14
AU2004308654B2 (en) 2008-11-20
JP4796506B2 (ja) 2011-10-19
JP2007516757A (ja) 2007-06-28
EP1699503B8 (en) 2012-11-07
ATE549044T1 (de) 2012-03-15
PL1699503T3 (pl) 2013-02-28

Similar Documents

Publication Publication Date Title
BRPI0418167A (pt) composições farmacêuticas
FR2938187B1 (fr) Composition injectable a base d'acide hyaluronique ou l'un de ses sels, de polyols et de lidocaine, sterilisee a la chaleur
AR051676A1 (es) Composiciones oftalmicas que comprenden polimeros sustituidos con polieter
SI2244752T1 (sl) Nizkoviskozni tekoči polimerni dovajalni sistem
DE60316115D1 (de) Dl-lactid-e-caprolacton copolymere
MX2008001706A (es) Conjugados de una porcion g-csf y un polimero.
ATE507816T1 (de) Injizierbare depotzusammensetzungen und deren verwendung
Dreger et al. Amino acid-based Poly (ester urea) copolymer films for hernia-repair applications
BRPI0407882A (pt) conjugados de polìmero-porção de fator viii
ATE366270T1 (de) Biologisch abbaubare copolymere, die an ein segment mit mehreren funktionellen gruppen gebunden sind
BRPI0416868A (pt) espuma absorvente, termoplástica, flexìvel, macia, de baixa densidade, de células abertas, artigo absorvente e método de fabricação da mesma
BG106451A (en) Glucopyranosyloxypyrazole derivatives, medicinal compositions containing the same and intermediates in the production thereof
BRPI0411862A (pt) combinações de substáncias ativas com propriedades inseticidas e acaricidas
ATE458773T1 (de) Abbaubare copolymere mit einem hydrophilen block mit verbesserter biokompatibilität für die weichgeweberegeneration
ATE325628T1 (de) Verstärkte, implantierbare vorrichtungen
SE0300010D0 (sv) Novel Compounds
CY1106476T1 (el) Υποκατεστημενες διυδροκιναζολινες με αντι-ιικες ιδιοτητες
DK1830661T3 (da) Ikke-klæbende tyggegummi
GT200200048A (es) Derivados de piperazina
CY1108377T1 (el) Χρηση ενωσεων 1-φαινυλο-3-διμεθυλαμινο-προπανιου για τη θεραπεια της ακρατειας ουρων
DE502005010427D1 (de) Physiologisch aktive zusammensetzung gegen diabetes
DE69923444D1 (de) Heterozyklische verbindungen mit faktor xa hemmender wirkung
ATE399572T1 (de) Katheterballon
DE602005025355D1 (de) Konjugate enthaltend gm-csf und ein polymer
BRPI0412357A (pt) combinações de substáncias ativas com propriedades inseticidas e acaricidas

Legal Events

Date Code Title Description
B06G Technical and formal requirements: other requirements [chapter 6.7 patent gazette]

Free format text: O PRESENTE PEDIDO FOI DEPOSITADO EM 23/12/2004. O PEDIDO DE EXAME FOI SOLICITADO ATRAVES DE PETICAONO NPRJ 020070183511 DE 26/12/2007. CONFORME DISPOE O ARTIGO 33 DA LPI9279/96, O EXAME DO PEDIDO DE PATENTE DEVERA SER REQUERIDO PELO DEPOSITANTE OU POR QUALQUER INTERESSADO, NO PRAZO DE 36 (TRINTA E SEIS) MESES CONTADOS DA DATA DE DEPOSITO, SOB PENA DO ARQUIVAMENTO DO PEDIDO.

B06H Technical and formal requirements: requirement cancelled [chapter 6.8 patent gazette]

Free format text: REF. A RPI NO 2150 DE 20/03/2012.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 10A E 11A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2342 DE 24-11-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.